CL
DBTX

CSS LLC’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

CSS LLC’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,800
Closed -$45K – 1235
2022
Q2 		$45K Buy
+10,800
New +$25.5K ﹤0.01% 954

Other funds holding DBTX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

CSS LLC's DBTX Position: Q3 2022 in Review

CSS LLC sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2022, closing a stake of 10,800 shares — an estimated $45K sold.

CSS LLC first reported a position in DBTX in Q2 2022 and held it in 1 quarter. The position peaked at $45K in Q2 2022. 40 funds tracked by Wall St. Rank hold DBTX as of Q3 2022.

  • CSS LLC reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • CSS LLC sold 10,800 Decibel Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $45K.
  • CSS LLC first reported a position in Decibel Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • CSS LLC's Decibel Therapeutics, Inc. Common Stock position peaked at $45K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.